Search Orphan Drug Designations and Approvals
-
Generic Name: | Angiotensin 1-7 |
---|---|
Date Designated: | 08/03/2001 |
Orphan Designation: | Treatment of myelodysplastic syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Tarix Pharmaceuticals, Ltd 12 Bow Street Cambridge, Massachusetts 02138 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-